Able View Global Inc. — FY2023 Form 20-F
Reporting period: Fiscal year ended December 31, 2023. This is an annual report; the supplied filing text does not provide standalone fourth-quarter results. Financial statements are prepared under U.S. GAAP. The company completed its business combination on August 17, 2023.
Business context
Able View manages international beauty and personal-care brands in China, earning most revenue by purchasing and reselling products through e-commerce marketplaces, distributors and direct-operated stores. It also began providing online-store operation services in 2022. The company reported 15 managed brands at year-end 2023; Clarins accounted for approximately 50% of revenue, underscoring brand concentration.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $149.0 million | $145.3 million |
| Gross profit / gross margin | $37.0 million / 25% | $32.5 million / 22% |
| Operating income | $13.3 million | $10.1 million |
| Net income | $9.75 million | $7.90 million |
| Operating cash flow | $23.6 million | $(12.8) million |
| Cash and cash equivalents, year-end | $13.3 million | $5.8 million |
| Accounts receivable, year-end | $14.5 million | $21.1 million |
| Inventory, year-end | $17.4 million | $18.7 million |
| Total liabilities, year-end | $43.5 million | $49.1 million |
| Shareholders’ equity, year-end | $11.4 million | $2.4 million |
Revenue increased about 3%, while gross profit rose about 14%, operating income about 31%, and net income about 23%. Product sales were $144.5 million, slightly below 2022; operation-services revenue increased to $4.5 million from $0.25 million. Selling and marketing expense declined 6% to $17.1 million, but general and administrative expense increased 59% to $6.5 million, mainly from higher professional fees, rent and inventory breakage. Net interest expense and foreign-exchange losses also increased.
Cash from operations improved substantially, supported in part by collecting older receivables and lower inventory, alongside increases in accounts payable and income taxes payable. Cash used in financing was $16.2 million, including repayments of borrowings. Current assets were $48.5 million and current liabilities $15.7 million at year-end. Short-term bank and other financial-institution loans were $2.9 million; the company also reported $26.4 million of noncurrent amounts due to related parties, including $15.8 million of declared but unpaid dividends and $10.7 million of other interest-free payables. Management believes cash and expected operating cash flows will cover working-capital needs and capital expenditures for the next 12 months.
Material changes and notable items
- Operating cash flow shifted from a $12.8 million use in 2022 to $23.6 million provided in 2023; receivables fell by $6.7 million year over year, while reported receivables turnover increased to 45 days from 40 days.
- Inventory turnover days rose to 60 from 46, despite a modest decline in year-end inventory.
- Accounts receivable had no recorded credit-loss allowance at year-end. Management cited collections and its assessment of customer creditworthiness.
- The 2023 revenue target for an earn-out of up to 1.6 million Class B shares was $170 million; the target was not met, so those shares were not earned. A separate 2024 earn-out target is $200 million, and management said it could not reasonably assess whether it would be met.
- The company reported 24.9 million Class A and 17.2 million Class B shares outstanding at year-end. Class A shares carry 10 votes each versus one vote for each Class B share; the CEO-controlled holder had approximately 93.6% of voting power.
Outlook, risks and contingencies
No quantified revenue or earnings guidance is provided. The company describes plans to add brands and channels, expand into functional beauty, OTC and wellness products, develop more business-to-business cross-border sales, and invest in data analytics and digital systems. These are plans, not financial guidance.
- Concentration and commercial exposure: Clarins contributed about 50% of revenue; brand contracts generally run 12–36 months and may not renew. E-commerce platforms can change terms or access, and major channels include Tmall and JD.com.
- Operating and working-capital risks: Able View owns inventory and bears inventory risk; receivables and inventory turnover days increased. Logistics, warehousing and delivery are substantially outsourced, and the company lacks business-interruption and product-liability insurance.
- China and currency risks: The business faces evolving PRC regulation, data and cybersecurity requirements, foreign-exchange controls, RMB volatility, and possible restrictions on moving funds or paying dividends. The company stated it was not then required to obtain PRC approvals for its U.S. listing, while noting regulatory uncertainty.
- Debt and related-party exposure: The filing describes significant borrowing activity and substantial related-party balances. Certain bank borrowing was secured by customer receivables. Related-party obligations include extended unpaid dividends and interest-free payables.
- Controls and reporting: Management concluded disclosure controls and internal control over financial reporting were ineffective at December 31, 2023 due to a material weakness: insufficient personnel with U.S. GAAP and SEC-reporting expertise. Remediation efforts included hiring a U.S. GAAP consulting firm and providing training. The auditor issued an unqualified opinion on the financial statements, but did not attest to internal-control effectiveness.
- Subsequent financing: A March 2024 loan agreement is described as having four tranches, while the filing calls the third tranche final. Three reported advances total approximately $2.88 million, at 5.05% annual interest and five-year maturities; confirm the final tranche terms and total commitment.
- Other unusual matters: A PRC subsidiary was fined RMB 32,400 and RMB 2,600 in 2022 for cosmetics advertising compliance issues. The company also reported a $6.16 million fair value for 1.12 million Class B shares issued to a financial adviser in connection with the business combination.
The company has no current plan to pay cash dividends. The filing reports $15.8 million of previously declared dividends still payable, with payment extended to January 2025. It reported no material pending legal or administrative proceedings, and the auditor’s report states the financial statements present fairly, in all material respects.
Most important facts for investors to verify
- Whether the company retains and renews Clarins and other key brand relationships, and how much revenue remains concentrated in its largest brand partners.
- Whether operating cash generation is sustainable after the 2023 working-capital recovery, and whether receivable and inventory days stabilize or worsen.
- The composition, repayment timing and terms of related-party obligations, including unpaid dividends, and the status of the March 2024 loan tranches.
- Progress in remediating the disclosed material weakness and whether future filings report effective controls.
- Whether the 2024 $200 million revenue earn-out target is achievable; the filing provides no quantified operating forecast.
- How PRC regulatory, currency-transfer and dividend restrictions affect access to cash held in China and distributions to the holding company.